27 May 2016, SwissTech Convention Center, Lausanne, Switzerland
Brain research is a priority for the European Union, which supported such research at the unprecedented level of more than €3 billion during the course of the EU Seventh Framework Programme for Research (FP7; 2007-2013). Brain research under FP7 addressed basic, translational and clinical research, and healthcare assessment. Horizon 2020, the EU Framework Programme for Research and Innovation (2014-2020) couples research to innovation, covering all forms of innovation from research to new products and services. Horizon 2020 offers many opportunities for support to brain research and innovation. International collaboration is an integral part of EU efforts and takes place via several courses. The European Union contributes to strengthen brain international cooperation, for instance via the International Initiative for Traumatic Brain Injury Research, or the Human Brain Project.
Collaborative research on health, including brain and brain diseases research, is mainly supported under the ‘Health, demographic change and well-being’ societal challenge. The horizontal nature of this societal challenge, not addressing specific diseases and areas, helps ensuring the cross-fertilisation of disciplines and approaches across the entire spectrum of the health innovation chain.
The public-private partnership between the EU and pharmaceutical industry – the Innovative Medicines Initiative 2 – is expected to greatly contribute to developing next generation medicines and treatments for neurodegenerative and psychiatric diseases.
Horizon 2020 also supports the coordination of national research efforts on brain research, through the European Research Area Network NEURON and the Joint Programming Initiative on Neurodegenerative Diseases Research (JPND).
Stakeholders of brain research are hence encouraged to seize the many opportunities offered under Horizon 2020 in order to advance knowledge on brain and brain diseases for the benefit of citizens and healthcare systems.
Dr. Catherine Berens joined the European Commission in Brussels in 2002, as a Scientific Officer in charge of Rare Diseases in the Health Directorate of Directorate-General for Research and Innovation. From 2012, she worked as a Policy Officer for Pharmaceuticals in the Directorate-General Enterprise and Industry, dealing with pricing and reimbursement of pharmaceuticals, and access to medicines. Since 2014 she has been the Head of Sector Neuroscience, at the Health Directorate of Directorate-General for Research and Innovation.
About The Brain Forum
The Brain Forum, first launched in 2013, brings together novel thinkers and pioneers in brain research, technology, healthcare and the economy. Researchers, engineers, healthcare professionals, entrepreneurs, industrialists, investors, funding agencies and policy makers meet at The Brain Forum 2016, to advance our understanding of how the brain works and to accelerate the application and value of this knowledge in society and the economy.
Channel: The Brain Forum
Categories: The Brain Forum,Videos
Video Views: 82 views
Original Publish Date: Published on Jun 17, 2016
Source URL: https://www.youtube.com/watch?v=Q7ubuKuvS2M